Evaluation of impact of serial hepatitis B virus DNA levels on development of hepatocellular carcinoma

Journal of Clinical Microbiology

Volumn 47, Issue 6, 2009, Pages 1830-1836

  Chan, Henry Lik Yuen ^a,b   Wong, Vincent Wai Sun ^a   Wong, Grace Lai Hung ^a   Chim, Angel Mei Ling ^a   Lai, Larry Hin ^a   Sung, Joseph Jao Yiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; PLACEBO; TELBIVUDINE; VIRUS DNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GENOTYPE; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 66749127339     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00029-09     Document Type: Article

References (29)

1. Chan, H. L. Y. 2002. Changing scene in hepatitis B serology interpretation. Hosp. Med. 63:16-19.
2. Chan, H. L. Y., N. W. Y. Leung, M. Hussain, M. L. Wong, and A. S. Lok. 2000. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31:763-768. (Pubitemid 30118648)
3. Chan, H. L. Y., Y. Hui, N. W. Y. Leung, J. Y. L. Ching, F. K. L. Chan, and J. J. Y. Sung. 2000. Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus (HBV) infected patients. Am. J. Gastroenterol. 95:3547-3551.
4. Chan, H. L. Y., A. K. K. Chui, W. Y. Lau, F. K. L. Chan, M. L. Wong, C. H. Tse, A. R. N. Rao, J. Wong, and J. J. Y. Sung. 2002. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation. J. Med. Virol. 68:182-187.
5. Chan, H. L. Y., S. W. C. Tsang, C. T. Liew, C. H. Tse, M. L. Wong, J. Y. L. Ching, N. W. Y. Leung, J. S. L. Tam, and J. J. Y. Sung. 2002. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am. J. Gastroenterol. 97:406-412.
6. Chan, H. L. Y., M. L. Wong, A. Y. Hui, L. C. T. Hung, F. K. L. Chan, and J. J. Y. Sung. 2003. Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B. J. Clin. Microbiol. 41:4793-4795.
7. Chan, H. L. Y., A. Y. Hui, M. L. Wong, A. M. L. Tse, L. C. T. Hung, V. W. S. Wong, and J. J. Y. Sung. 2004. Genotype C hepatitis B virus infection is associated with increased risk of hepatocellular carcinoma. Gut 53:1494-1498. (Pubitemid 39265273)
8. Chan, H. L. Y., and J. J. Y. Sung. 2006. Hepatocellular carcinoma and hepatitis B virus. Semin. Liver Dis. 26:153-161.
9. Chan, H. L. Y., C. H. Tse, F. Mo, J. Koh, V. W. S. Wong, G. L. H. Wong, S. L. Chan, W. Yeo, J. J. Y. Sung, and T. S. K. Mok. 2008. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma. J. Clin. Oncol. 26:177-182.
10. Chen, C. J., H. I. Yang, J. Su, C. L. Jen, S. L. You, S. N. Lu, G. T. Huang, U. H. Iloeje, and the REVEAL-HBV Study Group. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295:65-73.
11. Chen, G., W. Lin, F. Shen, U. H. Iloeje, W. T. London, and A. A. Evans. 2006. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am. J. Gastroenterol. 101:1797-1803.
12. Chu, C. J., M. Hussain, and A. S. F. Lok. 2002. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36:1408-1415. (Pubitemid 35407438)
13. Hadziyannis, S. F., and D. Vassilopoulos. 2001. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34:617-624. (Pubitemid 32927983)
14. Kao, J. H., P. J. Chen, M. Y. Lai, and D. S. Chen. 2003. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327-334. (Pubitemid 36169249)
15. Keeffe, E. B., D. T. Dieterich, S. H. B. Han, I. M. Jacobson, P. Martin, E. R. Schiff, H. Tobias, and T. L. Wright. 2006. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin. Gastroenterol. Hepatol. 4:936-962.
16. Kim, H., C. Nam, S. Jee, K. Han, D. Oh, and I. Suh. 2004. Normal serum aminotransferase concentration and risk of mortality from liver disease. BMJ 328:983-986.
17. Kim, W. R., S. L. Flamm, A. M. Di Bisceglie, H. C. Bodenheimer, Jr., and the Public Policy Committee of the American Association for the Study of Liver Disease. 2008. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:1363-1379.
18. Lampertico, P., M. Vigano, E. Manenti, M. Iavarone, E. Sablon, and M. Colombo. 2007. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology 133:1445-1451. (Pubitemid 350047463)
19. Liaw, Y. F., D. I. Tai, C. M. Chu, D. Y. Lin, I. S. Sheen, T. J. Chen, and C. C. Pao. 1986. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology 90:263-267. (Pubitemid 16136663)
20. Liaw, Y. F., J. J. Y. Sung, W. C. Chow, G. Farrell, C. Z. Lee, H. Yun, T. Tanwandee, Q. M. Tao, K. Shue, O. N. Keene, J. S. Dixon, F. Gray, J. Sabbat, and the Cirrhosis Asian Lamivudine Multicentre Study Group. 2004. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N. Engl. J. Med. 351:1521-1531.
21. Liaw, Y. F., N. Leung, J. H. Kao, T. Piratvisuth, E. Gane, K. H. Han, R. Guan, G. K. K. Lau, S. Locarnini, and the Chronic Hepatitis B Guideline Working Party of the Asian-Pacific Association for the Study of the Liver. 2008. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol. Int. 2:263-283.
22. Loeb, K. R., K. R. Jerome, J. Goddard, M. L. Huang, A. Cent, and L. Corey. 2000. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 32:626-629.
23. Lok, A. S. F., and B. J. McMahon. 2007. Chronic hepatitis B. Hepatology 45:507-539. (Pubitemid 46374607)
24. Prati, D., E. Taioli, A. Zanella, E. Della Torre, S. Butelli, E. Del Vecchio, L. Vianello, F. Zanuso, F. Mozzi, S. Milani, D. Conte, M. Colombo, and G. Sirchia. 2002. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 137:1-9.
25. Sherman, M., K. M. Peltekian, and C. Lee. 1995. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22:432-438.
26. Sung, J. J. Y., H. L. Y. Chan, M. L. Wong, C. H. Tse, S. C. H. Yuen, J. S. L. Tam, and N. W. Y. Leung. 2002. Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients. J. Viral Hepat. 9:229-234. (Pubitemid 36005522)
27. Wong, G. L. H., V. W. S. Wong, P. C. L. Choi, A. W. H. Chan, A. M. L. Chim, K. K. L. Yiu, H. Y. Chan, F. K. L. Chan, J. J. Y. Sung, and H. L. Y. Chan. 2008. Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography. Am. J. Gastroenterol. 103:3071-3081.
28. Yang, H. I., S. N. Lu, Y. F. Liaw, S. L. You, C. A. Sun, L. Y. Wang, C. K. Hsiao, P. J. Chen, D. S. Chen, C. J. Chen, and the Taiwan Community-Based Cancer Screening Project Group. 2002. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 347:168-174.
29. Yuen, M. F., H. J. Yuan, D. K. Wong, J. C. Yuen, W. M. Wong, A. O. Chan, B. C. Wong, K. C. Lai, and C. L. Lai. 2005. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut 54:1610-1614. (Pubitemid 41531781)